Searching across hundreds of databases
Despite the demonstration that amyloid-β (Aβ) can trigger increased tau phosphorylation and neurofibrillary tangle (NFT) formation in vivo, the molecular link associating Aβ and tau pathologies remains ill defined. Here, we observed that exposure of cultured primary neurons to Aβ trimers isolated from brain tissue of subjects with Alzheimer's disease led to a specific conformational change of tau detected by the antibody Alz50. A similar association was supported by postmortem human brain analyses. To study the role of Aβ trimers in vivo, we created a novel bigenic Tg-Aβ+Tau mouse line by crossing Tg2576 (Tg-Aβ) and rTg4510 (Tg-Tau) mice. Before neurodegeneration and amyloidosis, apparent Aβ trimers were increased by ∼2-fold in 3-month-old Tg-Aβ and Tg-Aβ+Tau mice compared with younger mice, whereas soluble monomeric Aβ levels were unchanged. Under these conditions, the expression of soluble Alz50-tau conformers rose by ∼2.2-fold in the forebrains of Tg-Aβ+Tau mice compared with nontransgenic littermates. In parallel, APP accumulated intracellularly, suggestive of a putative dysfunction of anterograde axonal transport. We found that the protein abundance of the kinesin-1 light chain (KLC1) was reduced selectively in vivo and in vitro when soluble Aβ trimers/Alz50-tau were present. Importantly, the reduction in KLC1 was prevented by the intraneuronal delivery of Alz50 antibodies. Collectively, our findings reveal that specific soluble conformers of Aβ and tau cooperatively disrupt axonal transport independently from plaques and tangles. Finally, these results suggest that not all endogenous Aβ oligomers trigger the same deleterious changes and that the role of each assembly should be considered separately.
Pubmed ID: 27629715 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Tau 210-230
View all literature mentionsThis monoclonal targets beta-Amyloid 1-16
View all literature mentionsThis monoclonal targets beta-Amyloid 1-16
View all literature mentionsThis monoclonal targets alpha-Tubulin antibody produced in mouse
View all literature mentionsThis polyclonal targets Actin
View all literature mentionsThis monoclonal targets actin
View all literature mentionsThis polyclonal targets EB3 antibody
View all literature mentionsThis polyclonal targets Dynein
View all literature mentionsThis polyclonal targets KIF5A
View all literature mentionsThis polyclonal targets KLC1 (H-75)
View all literature mentionsThis monoclonal targets Kinesin, Light Chain
View all literature mentionsThis monoclonal targets Neuron-Specific Nuclear Protein (NeuN)
View all literature mentionsThis monoclonal targets Alzheimer Precursor Protein A4, aa66-81 of APP
View all literature mentionsThis monoclonal targets beta-Amyloid 17-24
View all literature mentionsThis monoclonal targets alpha-Tubulin antibody produced in mouse
View all literature mentionsThis polyclonal targets Actin
View all literature mentionsThis monoclonal targets actin
View all literature mentionsThis polyclonal targets EB3 antibody
View all literature mentionsThis polyclonal targets Dynein
View all literature mentionsThis polyclonal targets KIF5A
View all literature mentionsThis polyclonal targets KLC1 (H-75)
View all literature mentionsThis monoclonal targets Kinesin, Light Chain
View all literature mentionsThis monoclonal targets Neuron-Specific Nuclear Protein (NeuN)
View all literature mentionsThis monoclonal targets Alzheimer Precursor Protein A4, aa66-81 of APP
View all literature mentionsThis monoclonal targets beta-Amyloid 17-24
View all literature mentionsThis monoclonal targets Tau 210-230
View all literature mentionsThis monoclonal targets beta-Amyloid 1-16
View all literature mentionsThis monoclonal targets beta-Amyloid 1-16
View all literature mentionsThis monoclonal targets beta-Amyloid 1-16
View all literature mentionsThis monoclonal targets beta-Amyloid 1-16
View all literature mentionsThis monoclonal targets Tau 210-230
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
